Interview: Paweł Mazur – East Area Director, Accord Healthcare, Poland
As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top…
Address:
Tel:
Web: http://www.neuca.pl/en/about-us/neuca-group
NEUCA is a group of financially connected companies offering a wide spectrum of services and products on the healthcare market in Poland. Main fields of activity include wholesale of pharmaceuticals to pharmacies, modern logistics, marketing and advertising services for pharmaceutical market as well as partnership programmes for independent pharmacies, IT services for pharmacies and individual pharmaceutical products.
Within the Capital Group there are several subsidiaries, all employing over 5 thousand people. The company’s headquarters is in Toruń. Two partnership programmes for independent pharmacies associate over 2.5 thousand entities.
The Capital Group is a pharmaceuticals wholesale market leader. Market shares at the end of 2009 amounted to 31.3%. Every day NEUCA reaches 9 thousand pharmacies all over Poland.
NEUCA was set up in 1990 as TORFARM S.A. In 2004 the company debuted on the Warsaw Stock Exchange. Since 2005 the company has become the most active and efficient subject active in the consolidation process of Polish pharmaceutical wholesale market reaching 20% market shares within three years only. The completion of the consolidation took place in mid 2009 with Prosper joining the Group and the market shares consequently growing by another 10%.
The Group operates in four crucial business areas:
WHOLESALE (subsidiary wholesale companies selling pharmaceuticals to pharmacies)
RETAIL (World of Health (Świat Zdrowia) and Good Price Pharmacy (Apteka Dobrych Cen))
OWN PRODUCTS (Synoptis Pharma)
SERVICES ON THE HEALTHCARE MARKET (NEKK marketing agency, ILC informatics company)
As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top…
Krzysztof Popławski, general manager of Baxter Poland, discusses the Baxter Education Center, the largest educational program for a European affiliate, and its role in raising the awareness within the Polish…
Hubert Niemyjski, country manager of Coloplast Poland and the Baltics, highlights the large differences between the market landscape of the company’s three pillars; ostomy, wound and continence care. Additionally, he…
Olympus is internationally well-regarded as being a quality camera provider and continues to provide developed countries across the globe with high-tech medical devices from endoscopes to imagery solutions. Tomasz Mrzygłód,…
Paweł Migdalski, CEO at Siemens Healthineers Poland, discusses the innovations they are bringing to the market and how they are building on the success of the Siemens Healthineers Academy. Furthermore,…
Tomasz Dzitko, founder and CEO of Delfarma, Poland’s leading parallel importer, gives an overview of the sector in Poland and its impact on the healthcare ecosystem, as well as the…
Piotr Steczniewski, president of Profarm PS – a successful wholesale family business – since 2012, shares how the company has managed to thrive over the years through constant adaptation to…
Łukasz Korybalski, regional manager of Becton Dickinson (BD) Central Eastern Europe, discusses the rising significance of the region as the company continues to grow and the strategic importance of Poland,…
Marzena Kulis, managing director of Johnson & Johnson Medical Devices CEE, highlights the importance of the region and Poland within J&J Medical Devices, and the impact of increasing healthcare expenditures…
Despite the global R&D excitement around oncology, cardiovascular death still remains the world’s largest killer, and according to OECD data, accounts for roughly a third of all mortalities. This trend…
Cezary Kilczewski, president and founder of Medicofarma, a Polish CMO, discusses the company’s recent upgrades to double production capacity and the move into R&D operations as well as the dynamics…
Andrzej Schonert, CEO of Synoptis Industrial, discusses the intricacies of the Polish market and the requirement to move into niche areas, mainly in Rx, to concentrate their pharmaceutical offering to…
See our Cookie Privacy Policy Here